Lavina Talukdar insider trades
Open-market stock purchases and sales by Lavina Talukdar, Director at Monopar Therapeutics, from SEC Form 4 filings since Mar 4, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 2, 2025 | MNPR Monopar Therapeutics | Bought (not open market) | — |
Companies traded
- MNPR Monopar Therapeutics: other filings, last Dec 2, 2025